MedPath

Comparison of the mean effect of Remifentanil, Methadone, and Sufentanil on Pain and Delirium in Patients with spinal surgery

Phase 3
Recruiting
Conditions
multiple fractures of spine, level unspecified.
Fracture of spine, level unspecified
Registration Number
IRCT20221218056854N1
Lead Sponsor
Ilam University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Patients with spinal surgery taking Remifentanil
Patients with spinal surgery taking Sufentanil
Patients with spinal surgery taking Methadone

Exclusion Criteria

Patients with Psychological History
Patients with History of Drug Addiction
Patients with History of Allergic Reaction to Drugs
Patients with History of Diabetes
Patients with History of Kidney Disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Delirium Severity and Duration. Timepoint: After Spinal Surgery, 6, 12, and 24 Hours After Surgery. Method of measurement: Physical Examination.;Four Main Delirium Features. Timepoint: After Spinal Surgery, 6, 12 and 24 Hours After Surgery. Method of measurement: CAM-ICU(Confusion Assessment Method for the Intensive Care Unit) Questionnaire.;Pain Intensity Score. Timepoint: After Spinal Surgery, 6, 12 and 24 Hours After Surgery. Method of measurement: Visual Analog Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath